Today: 14 May 2026
Browse Category

Financial Forecasts 21 December 2025 - 22 December 2025

Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI announced two new U.S. patents on Dec. 22 for blockchain-based content licensing and tokenized monetization. Shares traded near $0.97 early Monday, down about 9.6% from the prior close, with volume spiking to around 94 million shares. The company’s stock has swung between $0.25 and $4.10 over the past year.
22 December 2025
···
BP PLC Stock Outlook (Dec. 22, 2025): New CEO Meg O’Neill, Buybacks, and 2026 Oil Price Forecasts Put BP Shares in Focus

BP PLC Stock Outlook (Dec. 22, 2025): New CEO Meg O’Neill, Buybacks, and 2026 Oil Price Forecasts Put BP Shares in Focus

BP confirmed Meg O’Neill will become CEO on April 1, 2026, following Murray Auchincloss’s abrupt exit. Shares traded at 424.5p in London and $33.94 in New York as of December 22. The board is pushing for tighter cost controls and asset sales amid persistent takeover speculation. BP is running active share buybacks while oil prices remain range-bound.
22 December 2025
····
Unilever PLC Stock (ULVR, UL) News and Forecasts on Dec. 22, 2025: Post–Magnum Spin-Off Outlook, Analyst Targets, and Key Risks

Unilever PLC Stock (ULVR, UL) News and Forecasts on Dec. 22, 2025: Post–Magnum Spin-Off Outlook, Analyst Targets, and Key Risks

Unilever completed the demerger of its ice cream business, now The Magnum Ice Cream Company, and consolidated shares at an 8-for-9 ratio. As of Dec. 22, shareholders began receiving TMICC share statements and fractional cash payments. Citadel disclosed a £50 million short position against Magnum. Unilever retains a 19.9% stake in the spun-off company.
22 December 2025
···
Lenskart Solutions Limited Stock Today (22 December 2025): Share Price, Macquarie’s ₹530 Target, Morgan Stanley View, and Fresh Forecasts

Lenskart Solutions Limited Stock Today (22 December 2025): Share Price, Macquarie’s ₹530 Target, Morgan Stanley View, and Fresh Forecasts

Lenskart shares traded around ₹475–₹478 mid-day on December 22, after swinging between ₹454.65 and ₹495.00. Macquarie started coverage with an “Outperform” rating and ₹530 target, citing margin potential, while Morgan Stanley initiated at “Equal-weight” with a ₹445 target, highlighting valuation concerns. The stock is up about 14% over the past month. Market cap stands near ₹81,000–₹82,000 crore.
22 December 2025
··
Lynas Rare Earths (ASX:LYC) Stock News, Forecasts and Analyst Outlook (22 December 2025)

Lynas Rare Earths (ASX:LYC) Stock News, Forecasts and Analyst Outlook (22 December 2025)

Lynas Rare Earths will join the S&P/ASX 50 index before market open on 22 December 2025, following S&P Dow Jones Indices’ quarterly rebalance. The company faces near-term production shortfalls after power disruptions at its Kalgoorlie facility, which have led analysts to cut output and revenue forecasts for the December quarter. Lynas shares closed at A$12.49 on Monday, up 2.46%.
22 December 2025
··
National Australia Bank (ASX: NAB) Share Price Today: What’s Moving NAB Stock on 22 December 2025 — and Where Analysts See It Heading

National Australia Bank (ASX: NAB) Share Price Today: What’s Moving NAB Stock on 22 December 2025 — and Where Analysts See It Heading

NAB shares traded near A$42.08 on December 22, 2025, down for the day while some peers outperformed in a shortened Christmas week. The stock’s 52-week range stood at A$31.13 to A$45.25. Market focus remains on shifting rate expectations, with some analysts now forecasting RBA hikes as early as February. Broader consensus on the RBA’s next move remains uncertain.
22 December 2025
··
Boeing Stock (BA) Preview for Dec. 22, 2025: FAA Decisions, 777F Emissions Waiver, and the 2026 Cash-Flow Turnaround Debate

Boeing Stock (BA) Preview for Dec. 22, 2025: FAA Decisions, 777F Emissions Waiver, and the 2026 Cash-Flow Turnaround Debate

Boeing shares closed at $214.08, up 2.79% ahead of a holiday-shortened trading week. Investors are watching FAA certification progress for the 737 MAX 7 and 10, as delays continue to affect delivery schedules and cash flow outlooks. NYSE and Nasdaq confirmed normal trading hours except for an early close on Dec. 24 and closure on Dec. 25.
22 December 2025
·
Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm closed at $175.25 on Dec. 19, 2025, with after-hours trading at $175.75 and a market cap near $186 billion. The company completed its Alphawave Semi acquisition on Dec. 18, accelerating its data center AI push. Tony Pialis, Alphawave’s CEO, will lead Qualcomm’s data center business. Next earnings are scheduled for Feb. 4, 2026.
22 December 2025
···
Disney Stock Forecast: Key Catalysts for Walt Disney (DIS) Shares in the Week Ahead (Dec. 22–26, 2025)

Disney Stock Forecast: Key Catalysts for Walt Disney (DIS) Shares in the Week Ahead (Dec. 22–26, 2025)

Disney shares traded near $111 ahead of the Christmas-shortened week, as the company announced a $1 billion partnership with OpenAI to license over 200 characters for AI video tools. The NYSE will close early Dec. 24 and remain shut Dec. 25. Disney stock remains about 10% below its 52-week high. Thin holiday trading could amplify price swings.
22 December 2025
··
The Trade Desk (TTD) Stock Week Ahead: Nasdaq-100 Exit, Fresh Analyst Targets, and Key Catalysts for Dec. 22–26, 2025

The Trade Desk (TTD) Stock Week Ahead: Nasdaq-100 Exit, Fresh Analyst Targets, and Key Catalysts for Dec. 22–26, 2025

The Trade Desk will be removed from the Nasdaq-100 before markets open Monday, Dec. 22, triggering index-related selling in a holiday-shortened week with thin liquidity. Shares last traded near $37 on Friday, Dec. 19. The company also confirmed layoffs affecting less than 1% of staff. U.S. markets close early Dec. 24 and remain shut Dec. 25.
22 December 2025
··
Rivian (RIVN) Stock Week-Ahead Outlook: Key Catalysts, Analyst Forecasts, and What to Watch (Dec. 22–26, 2025)

Rivian (RIVN) Stock Week-Ahead Outlook: Key Catalysts, Analyst Forecasts, and What to Watch (Dec. 22–26, 2025)

Rivian shares closed at $22.45 on Friday, Dec. 19, 2025, up 10% and near a 52-week high after a December rally. The stock now trades well above the average analyst target of $16.91, following headlines on Rivian’s custom autonomy chip and new subscription pricing for Autonomy+, set to launch in early 2026.
22 December 2025
···
Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen shares closed at $174.80 on Dec. 19, up 2.88% with trading volume spiking to 15 million shares, well above the 50-day average. The stock remains about 5% below its 52-week high of $185.17. Recent filings show new institutional positions from Wedge Capital Management and Fluent Financial. Leqembi was added to China’s Commercial Insurance Innovative Drug List, effective Jan. 1, 2026.
21 December 2025
··
Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch

Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch

Rocket Lab shares closed at a record $70.52 Friday after winning an $816 million U.S. Space Development Agency contract to build 18 missile-warning satellites. The deal is Rocket Lab’s largest and could push total SDA contract value above $1.3 billion. Investors are watching whether the company can deliver on defense backlogs and advance its Neutron rocket program.
21 December 2025
····
Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)

Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)

Amgen shares last traded near $327.38 as investors weighed a new FDA label expansion and U.S. drug-pricing deals announced Dec. 19. The NYSE will close early Dec. 24 and remain shut Dec. 25, thinning liquidity and increasing volatility risk. Amgen, a Dow component, remains sensitive to policy headlines and year-end positioning.
21 December 2025
···
Exxon Mobil Stock (XOM) Week Ahead Outlook: Oil Prices, Analyst Targets, and Key Catalysts for Dec 22–26, 2025

Exxon Mobil Stock (XOM) Week Ahead Outlook: Oil Prices, Analyst Targets, and Key Catalysts for Dec 22–26, 2025

Exxon Mobil shares last traded near $116.69 as investors react to the company’s upgraded 2030 plan, which projects $25 billion in earnings growth and $35 billion in cash flow growth by 2030. The NYSE will close early at 1 p.m. ET on Dec. 24 and remain shut Dec. 25, with normal trading resuming Dec. 26. CFO Kathy Mikells will retire Feb. 1, 2026.
21 December 2025
····
Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Ondas Holdings shares jumped 18% to $9.22 on Dec. 19, 2025, with trading volume surging to 125.8 million shares after a series of acquisitions and contract wins. The company appointed Brig. Gen. Patrick Huston as COO on Dec. 18 and reported a successful Middle East demining pilot. Ondas also disclosed a late-December capital-structure change involving new share issuance and a Q4 non-cash charge.
21 December 2025
··
Palantir (PLTR) Stock Week Ahead: Latest News, Catalysts, and Forecasts for Dec. 22–26, 2025

Palantir (PLTR) Stock Week Ahead: Latest News, Catalysts, and Forecasts for Dec. 22–26, 2025

Palantir shares closed at $193.38 on Dec. 19 after heavy trading and a volatile session. The company reported Q3 revenue growth of 63% year over year and raised its 2025 revenue outlook to about $4.4 billion. Palantir recently expanded its partnership with Accenture and renewed a three-year contract with France’s DGSI. Markets face a shortened holiday week and key macroeconomic data releases.
21 December 2025
··
Recursion Pharmaceuticals RXRX Stock News and Forecasts on December 21 2025

Recursion Pharmaceuticals RXRX Stock News and Forecasts on December 21 2025

Recursion Pharmaceuticals (RXRX) closed at $4.26 on December 19, 2025, with a market cap of about $2.1 billion after releasing Phase 1b/2 data for REC‑4881 in familial adenomatous polyposis. The trial showed a median 43% reduction in polyp burden at 13 weeks and 53% at 25 weeks. REC‑4881 has Fast Track and Orphan Drug status from the FDA and EU. Trading volume was heavy, with sentiment split on commercialization prospects.
21 December 2025
···
1 … 7 8 9 10 11 … 42

Stock Market Today

  • NGEx Minerals Shares Surge 12.7% on Lunahuasi Drilling Results and Adit Approval
    May 13, 2026, 8:06 PM EDT. NGEx Minerals (TSX:NGEX) shares rose 12.7% after announcing completion of its Phase 4 drilling program at the Lunahuasi copper-gold-silver project in Argentina, featuring high-grade intersections. The company also secured environmental approval for an underground exploration adit, expanding future drilling and sampling options. These developments support the investment narrative that hinges on assay results shaping the potential scale of deposits at Mars, Saturn, Jupiter, and new zones. Despite the positive news, investor caution remains due to ongoing losses, funding needs, and risks that drill results may not translate into an economic mine. Shares remain volatile with a wide valuation range among analysts, reflecting differing views on exploration success and project risk.

Latest articles

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

14 May 2026
USA Rare Earth reported Q1 revenue of $5.7 million and a net loss of $67 million, ending March with $1.75 billion in cash after a $1.5 billion PIPE. The company expects to sign documents this month for $1.6 billion in U.S. Commerce Department funding. Texas awarded a $14.18 million grant for the Round Top project. USA Rare Earth agreed in April to acquire Brazil’s Serra Verde for $2.8 billion.
Go toTop